Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...

The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.

Jabil Inc. closed 6.96% short of its 52-week high of $174.80, which the company achieved on January 24th.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience ...